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The St. Lawrence River estuary (SLE),
Québec, Canada, receives the effluent from
one of the most industrialized regions of the
world (Figure 1). It is inhabited by the south-
ernmost population of beluga (Delphinapterus
leucas), a population unique in its accessibility
to investigation and its geographic isolation
from the Arctic habitat where the other popu-
lations of beluga are found. The SLE beluga
population has dwindled from an estimated
5,000 to the current estimated 600–700 ani-
mals, in part because of the hunting pressure
that continued until 1979 (1–3). Because of
this dramatic decline, SLE belugas received
the status of endangered species from the
Canadian government in 1980 (3). Yet no
solid data indicate population recovery. To
explain this apparent failure to recover, we
initiated a study in 1982 to carry out system-
atic postmortem examination of dead SLE
beluga that drift ashore and to determine tis-
sue levels of chemical contaminants.
Live and dead SLE beluga are heavily
contaminated by agricultural and industrial
contaminants such as heavy metals, poly-
cyclic aromatic hydrocarbons (PAHs), 
and polychlorinated biphenyls (PCBs),
dichlorodiphenyltrichloroethane (DDT),
and their metabolites(4–8).
In this article we present an overview of
the results of necropsies conducted over 17
years (1983–1999). The rate of cancer in the
SLE beluga population is higher than in any
other population of wild terrestrial or
aquatic animals.
Materials and Methods
The public and officials of various govern-
ment agencies reported carcasses found
dead stranded on the shoreline, which were
transported to the postmortem room of the
Faculté de Médecine Vétérinaire de
l’Université de Montréal, 500 km to the
southwest, where pathologists assisted by
veterinary students examined them upon
arrival. Samples of all organs and lesions
were preserved in neutral 10% buffered for-
malin; fixed tissues were embedded in
paraffin, sectioned 5–7 µm thick, and rou-
tinely stained with hematoxylin-phloxin-
saffron. Special stains were used when
needed.
We submitted all tumors to the
Department of Veterinary Pathology of the
Armed Forces Institute of Pathology (AFIP;
Washington, DC) for archiving in the
Marine Mammal Database and/or for con-
sultation purposes.
We determined the age of 190 carcasses
by counting dentine growth layers on longi-
tudinal section of teeth, using the standard
of two growth layers per year (9).
The standardized rate ratio of digestive
system cancer in both men and women in
Québec takes into account the standardized
rate ratio for each health unit in Québec (10).
This ratio represents the number of new cases
of cancer diagnosed and reported in the
province of Québec during the speciﬁed time
period (1989–1993) divided by the expected
incidence over the same period. These ratios
were represented geographically using
Arcview version 3.2 (ESRI, Redlands, CA). 
The Centre Hospitalier Universitaire de
Québec provided all the human cancer epi-
demiologic data.
Results
Mortality. The study was initiated in
September 1982, but in this review we
include only complete years between 1983
and 1999. During this time period, 263 bel-
ugas were found dead, drifting, or stranded
along the SLE shoreline. We examined 129
carcasses in the postmortem room. Of these,
we considered 100 to be reasonably well pre-
served (77%) based on the ﬁrm consistency
of the liver. Eighty of the relatively fresh 100
belugas (80%) were adult (> 7 years old).
To interpret the data presented here, the
following observations must be considered.
First, 51% (134 of 263) of stranded reported
animals have not been necropsied, so the
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Articles
A population of approximately 650 beluga (Delphinapterus leucas) inhabits a short segment of the
St. Lawrence estuary (SLE). Over 17 years (1983–1999), we have examined 129 (or 49%) of 263
SLE beluga carcasses reported stranded. The major primary causes of death were respiratory and
gastrointestinal infections with metazoan parasites (22%), cancer (18%), and bacterial, viral, and
protozoan infections (17%). We observed cancer in 27% of examined adult animals found dead, a
percentage similar to that found in humans. The estimated annual rate (AR) of all cancer types
(163/100,000 animals) is much higher than that reported for any other population of cetacean
and is similar to that of humans and to that of hospitalized cats and cattle. The AR of cancer of
the proximal intestine, a minimum ﬁgure of 63 per 100,000 animals, is much higher than that
observed in domestic animals and humans, except in sheep in certain parts of the world, where
environmental contaminants are believed to be involved in the etiology of this condition. SLE
beluga and their environment are contaminated by polycyclic aromatic hydrocarbons (PAHs) pro-
duced by the local aluminum smelters. The human population living in proximity of the SLE bel-
uga habitat is affected by rates of cancer higher than those found in people in the rest of Québec
and Canada, and some of these cancers have been epidemiologically related to PAHs. Considered
with the above observations, the exposure of SLE beluga to PAHs and their contamination by
these compounds are consistent with the hypothesis that PAHs are involved in the etiology of
cancer in these animals. Key words: aluminum, beluga, cancer, cetaceans, pollution, polycyclic
aromatic hydrocarbons, whale, wildlife. Environ Health Perspect 110:285–292 (2002). [Online
12 February 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p285-292martineau/abstract.htmlcause of death and lesions affecting these
animals remain unknown. The number of
animals stranded dead during winter is also
unknown. In the spring, summer, and fall,
carcasses with terminal diseases are often
found after several days of rough weather,
suggesting that the number of strandings
occurring during winter is at least the same
as that reported during the rest of the year,
because of the harsh weather conditions pre-
vailing in that season. Young calves (< 1
year) are difﬁcult to ﬁnd in the wild because
of their small size and blue-gray color.
Therefore, calf mortality is probably under-
estimated.
A mathematical model suggests that
there are fewer live animals in the 21- to 25-
year age group in the SLE population than
in the northwest Alaska (NA) population
(11,12). Yet stranded dead SLE beluga in
that age group died in higher numbers; SLE
beluga stranded dead had a mortality peak
between 21 and 25 years (Figure 2) (13). In
NA beluga, the estimated age-speciﬁc death
rate per age class is highest in the 0–5 year
group, decreases abruptly in the 6–10 year
age group, and then decreases slowly until
maximum life span (38 years). Thus, the age
structure of SLE beluga dying of natural
causes appears clearly different from that of
NA beluga, principally because most SLE
belugas die at an earlier age (between 21 and
25 years old).
Primary causes of death and types of
cancer. Overall, the three primary causes of
death of SLE beluga were metazoan parasites
(22%), cancer (18%), and infectious agents
(bacterial, viral, or protozoan, 17%) (Figure
3). The major cause of death in adult beluga
(n = 79) was cancer. We found 21 cancers in
the 100 well-preserved carcasses examined,
and of these, excluding the ovarian tumors,
18 were terminal (cancers that led to death).
Thirty percent (6 of 21) of the cancers
affecting SLE beluga originated from the
intestine close to the stomach, whereas a sev-
enth intestinal cancer was closer to the anus
(14). All other cancers are listed in Table 1.
Cancer epidemiology in SLE beluga. The
annual rate of cancer in the SLE beluga pop-
ulation was estimated as the number of new
cases of cancers per year. The estimated
annual rate (AR) was calculated, as in Dorn
et al. (15), as an annual rate per 100,000
animals. The actual number of stranded SLE
beluga with cancer that were examined in
the necropsy room was divided by 17 years
(1983–1999) and by the estimated number
of SLE beluga, and the result was multiplied
by 100,000 animals. A recent index estimate
of 650 SLE belugas was used (1,16).
[1]
where AR is the estimated annual rate of
cancer in SLE beluga, SLB is the beluga
inhabiting the SLE, and t is the study period
(1983–1999).
Stranded carcasses are rarely reported in
winter (January–March) because of the ice
cover, difficult access to most of the shore-
line, inclement weather, and the presence of
few human observers on the shoreline. To
estimate the number of dead animals that
strand over a complete year, we assumed that
the frequency of death during the winter
months is equal to that of other seasons
(although it is probably higher for the above
reasons), so we used a correction factor of 12
months/9 months (1.33). Assuming that all
carcasses have an equal chance of being seen
and collected whatever the cause of death,
we estimated the minimum number of SLE
beluga with cancer (estimated minimum
with cancer, EMC) over the last 17 years
(1983–1999) as follows:
where EMC is the estimated minimum
number of SLE beluga with cancer per year,
and Dead SLB is the total number of beluga
reported dead and/or examined during the
study period (1993–1999). The adjusted
estimated annual rate (AAR) of cancer for a
complete year (12 months) is:
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Figure 1. Distribution of beluga in the SLE and incidence of standardized rate ratio for digestive system cancer in (A) men and (B) women in Québec.
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Figure 2. Age structure of SLE beluga found dead
on the shoreline (1983–1997) compared with that
of NA beluga obtained through subsistence hunt-
ing. We took the data for NA beluga from Alaska
Department of Fish and Game’s (13) Table 7
(model population of 1,000 beluga), from the col-
umn labeled number of deaths per 1,000 beluga.
We divided the latter figures by 10 to obtain a
model population of 100 beluga. 
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where SLB is the beluga inhabiting the SLE
and t is the study period (1993–1999).
Discussion
Sample representativeness. This study has
been carried out well over a decade.
Considering the beluga life span (35–40
years), a sizable proportion of the population
died and has been examined over this period.
Except for young calves (< 1 year) and for the
winter season, it is assumed that all carcasses
have equal chances of being recovered and
examined whatever the cause of death, for
the following reasons: These whales live in a
restricted range, as shown by thorough sur-
veys from airplanes and boats (1,17,18); all
carcasses have been found within that range
or downstream, as a result of drift; and we
used no criteria other than reasonable preser-
vation and carcass accessibility to determine
whether a given carcass would be examined
in the postmortem room. In conclusion,
although some deaths may occasionally
escape our attention, the sampling of car-
casses is most likely representative of the pop-
ulation in terms of causes of mortality.
Comparison of SLE beluga whales with
other cetaceans. Cancers in stranded SLE bel-
uga are more numerous than in other
cetaceans, where cancer is a rare event and
where major causes of death are, excluding
recent viral epizootics, entanglement in ﬁshing
gear, pneumonia and/or parasitism, and aban-
donment and starvation of neonates (19–21).
No tumors were observed in 19 car-
casses of other species of marine mammals
living in the SLE and examined by a veteri-
nary pathologist during the same period,
using the same postmortem examination
protocol (22). Only 33 cases of cancer have
been reported worldwide in captive and
wild cetaceans other than SLE beluga
(Tables 1–3).
The types of cancer seen in SLE beluga
also differ widely from those seen in other
cetaceans (Tables 2 and 3). Gastrointestinal
epithelial cancers were the most frequent
cancers seen in SLE beluga; in contrast,
hemopoietic cancers are the most frequent
types of cancer observed in other cetaceans
(Tables 1–3). Only one of the 33 cancers
(3%) seen in other cetaceans was a gastroin-
testinal epithelial cancer. Furthermore, no
mammary gland cancers had been previously
reported in other cetaceans, whereas three of
these cancers have been reported in SLE
beluga (23).
A single cancer was found in over 1,800
other cetaceans examined, and tumors were
not found in approximately 50 beluga exam-
ined in the Canadian Arctic [D.J. St. Aubin,
personal communication, cited in (22)].
Arctic data may not be fully representative,
however, because the age of Arctic beluga
was unknown and these were randomly
selected live animals and not stranded ani-
mals that died spontaneously. A single
benign tumor was observed in 55 slaugh-
tered pilot whales in Newfoundland (24),
and only two benign tumors (0.1%) were
reported in 2,000 mysticetes (baleen whales)
hunted in South Africa (19).
The present study can best be compared
with studies on singly stranded cetaceans
rather than with studies performed on
cetaceans shot or caught singly or collectively
in ﬁshing gears. None of these studies have
shown a cancer rate comparable to that of
SLE beluga. Neoplasia was not observed in
86 small odontocetes stranded on the
Oregon and California shoreline (20,21).
Among 90 bottlenose dolphins (Tursiops
truncatus) stranded along the Gulf coast of
Texas from 1991 to 1998, two cancers (or
2%), a myelogenous leukemia and a bile
duct carcinoma, were found (25). No can-
cers were found in 28 harbor porpoises
stranded on the British coast (26). Three
cancers were found during the postmortem
examination of 422 odontocetes (or 0.7%)
from British waters (27), and a retrovirus
may have been the etiologic agent of five
lymphomas observed in dolphins on the
American East Coast (28).
Comparison with other species. In the
Western world, cancer causes 23% of all
deaths in humans, a percentage comparable
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Figure 3. Primary causes of death in the SLE beluga (B) between 1983 and 1999 compared with those of
roe deer (A) in Sweden between 1985 and 1995 (32).
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Table 1. Cancers reported in stranded beluga from the SLE (1983–1999).
Age AFIP accession
Organ Cancer type Identiﬁcation (years) Sex Reference number
Intestine Adenocarcinoma 8907  ≥ 29.5 M (22) 2462295–3
Intestine Adenocarcinoma 8908  ≥ 20.5 M (22) 2462247–4
Intestine Adenocarcinoma 9302  ≥ 25 M (14) 2461200
Intestine Adenocarcinoma 9402  ≥ 27.5 M (14) 2464226–6
Intestine Adenocarcinoma 9407  ≥ 27 F (11) 2582000
Intestine Adenocarcinoma 9605  ≥ 23 F Unpublished 2573961–6
Intestine Adenocarcinoma 9809 ≥ 18 M Unpublished 2732611–00
Skin Squamous cell  Same animal
carcinoma (9809)
Stomach Adenocarcinoma 8804  ≥ 21 F (22) 2456949–3
Stomach Adenocarcinoma 9401  ≥ 27.5 M (11)2 508095–300
Salivary gland Adenocarcinoma 8606  ≥ 24.5 M (81) 2457053–3
Mammary gland Adenocarcinoma 8809 ≥ 22 F (22) 2456952–7
(Liver) Poorly differentiated Same animal 
carcinoma, probably (8809)
a metastasisa
Mammary gland Adenocarcinoma 9804 20.5 F (23) 2674669 00
Mammary gland Adenocarcinoma 9803 ≥ 26 F (23) 2674861 00
Uterus Adenocarcinoma 9502  ≥ 26 F (82) 2573966–5
All organs Metastatic carcinoma 9609  ≥ 23 M Unpublished 2656322–1 00
Ovary Granulosa cell tumor 8502  24.5 F (5) 2519612
Ovary Granulosa cell tumor 8813  ≥ 21 F (22) 2462292–0
Ovary Dysgerminomab 8906 ≥ 25 F (22) 2462229–2
Thymus Lymphosarcoma 9001 ≥ 18.5 M (22) 2519747
Neuroendocrine Carcinoma 9905 11 F Unpublished 2732823–00
Urinary bladder Transitional cell carcinoma 8318  16.5 M (83)
aWas originally classiﬁed as a primary liver cancer [beluga no. 5 in Kingsley and Hammill (18)]; reclassiﬁed as metastasis
after consultation with AFIP. bWas originally classiﬁed as Granulosa cell tumor [beluga no. 16 in Kingsley and Hammill
(18)]; reclassiﬁed as dysgerminoma after consultation with AFIP.to that seen in SLE beluga (29). In wild ani-
mal populations, cancer has not been
reported as a major cause of mortality in
adults, with the possible exception of virus-
induced liver cancer in woodchuck and
retrovirus-induced leukemia in rodents
(30,31). Instead, trauma and starvation are
among the most frequent causes of death
(Figure 3) (32). Both viruses and carcino-
genic contaminants have been suspected to
cause a high prevalence of metastatic carci-
nomas in California sea lions (33).
In veterinary and human epidemiology,
the number of individuals at risk must be
known precisely in order to determine dis-
ease prevalence. This requirement explains
why few epidemiologic cancer studies have
been carried out in wild mammal popula-
tions, which are notoriously ill defined
and/or widespread. SLE belugas are an
exception in this regard. This population is
reasonably well characterized, geographically
isolated, and restricted to a relatively small
area and has been the object of numerous
censuses often carried out using different
techniques (1,17,18). All censuses have pro-
vided similar results, so the population at
risk—the denominator used to calculate the
AR (15)—is reasonably well deﬁned.
We compared the AR and the AAR with
those of domestic animals and humans
(Figure 4). The AR of cancer, of epithelial
cancer of the proximal intestine, of gastric
cancer, of gastrointestinal epithelial cancer,
and of mammary cancer was generally higher
in SLE beluga than in domestic animals seen
in veterinary hospitals. For all types of can-
cer, with the exception of mammary gland
cancer, the SLE beluga AAR was higher than
that in all other animal species and in
humans. The AAR of mammary gland can-
cer was the same as the rate seen in humans
and was comparable to the rate seen in dogs
examined in veterinary hospitals (Figure 4).
Paradoxically, the collection of epidemio-
logic data from the SLE population resem-
bles more closely that of humans than that of
domestic animals because the denominator
Articles • Martineau et al.
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Table 2. Cancers reported in cetaceans other than SLE beluga.
Species (no.) Organ Cancer Age Sex Sources Reference
Bottlenose dolphin Liver, lungs Reticuloendotheliosis U F U Ridgway, 
pers. comm. in (84)
Bottlenose dolphin (3) Multisystemic Immunoblastic malignant lymphoma Adults F Florida (28)
Atlantic spotted dolphin (1) Multisystemic Immunoblastic malignant lymphoma Adult F Florida
Pantropical spotted dolphin (1) Multisystemic Immunoblastic malignant lymphoma Adult F Florida
Bottlenose dolphin Blood Myelogenous leukemia Adult F Gulf coast of Texas (25)
Bottlenose dolphin Liver Cholangiocarcinoma Adult Gulf coast of Texas (85)
Bottlenose dolphin Spleen, lymph nodes Lymphosarcoma Adult F U Taylor and Greenwood, 
pers. comm. in (84)
Paciﬁc white-sided dolphin Spleen, lymph nodes Lymphosarcoma Adult M U (21)
Paciﬁc white-sided dolphin Spleen, lymph nodes, 
liver, kidney Eosinophilic leukemia Adult M U (21)
Bottlenose dolphin Pancreas Carcinoma Adult M U Taylor and Greenwood, 
pers. comm. in (84)
Pilot whale Ovary Granulosa cell tumor Adult F U (86)
Harbor porpoise Unknown Adenocarcinoma F British waters (87)
Harbor porpoise Stomach Adenocarcinoma Adult F Northern Wadden Sea (88)
Amazon River dolphin Lung Squamous cell carcinoma Adult F U (65)
Blue whale Ovary Granulosa cell tumor Adult F Antarctic (89)
Fin whale Ovary Granulosa cell tumor Adult F Antarctic (89)
Fin whale Ovary Granulosa cell tumor Adult F Antarctic (89)
Fin whale Ovary Carcinomaa Adult F Antarctic (90)
Abbreviations: F, female; M, male; pers. comm., personal communication; U, unknown. 
aReclassiﬁed as granulosa cell tumor in Geraci et al. (65). 
Table 3. Cetaceans affected by cancer listed in the Marine Mammal Database, AFIP (updated April 2001).
Accession
Species Status Organ Cancer type Age Sex Sources Percent (n)a number
Beluga Captive Brain Carcinoma 19 years M Arctic 1.7 (56) 2034441
Bottlenose dolphin Wild U Tubulopapillary adenocarcinoma Adult M Gulf of Mexico 0.5 (790) 2304654
Bottlenose dolphin Wild Kidney Renal cell carcinoma Adult F Atlantic Ocean 0.5 (790) 2445679
(South Carolina)
Bottlenose dolphin Wild U Metastatic adenocarcinoma of  U F Florida 0.5 (790) 2668101
unknown origin
Bottlenose dolphin Wild Multiple organs  Malignant seminoma Adult M Atlantic Ocean  0.5 (790) 2660824
(North Carolina)
Common dolphin (D. delphis) Wild Multiple organs  Anaplastic carcinoma (primary  Adult M California coast 2.6 (77) 2529715
site undetermined)
Common dolphin (D. delphis) Wild Multiple organs Solid carcinoma (primary site  Adult M New Jersey coast 2.6 (77) 2582000
undermined)
Fin whale Wild Kidney Lymphosarcoma Adult F U 1.5 (8) 1470245
Killer whale Captive Liver, lymph node,  Reticuloendotheliosis Adult F U 6.2 (32) 1626236
spleen
Killer whale Captive Lymph node Hodgkin disease-like (91) Adult M Iceland 6.2 (32) 2337420
Pygmy sperm whale U Liver Cholangiocarcinoma U U U 0.9 (110) 1777514
Spotted dolphin (Stenella Wild Testis, lymph nodes,  Malignant seminoma,  Adult M Gulf of Mexico 6.8 (30) 2428264
frontalis) adrenal glands pheochromocytoma
Spotted dolphin (S. frontalis) Wild Multiple organs Malignant lymphoma 1 year F Gulf of Mexico 6.8 (30) 2660824
Abbreviations: F, female; M, male; U, unknown. AFIP others: brain (1 animal), kidney (1), testis and adrenals (1), ND (3). 
a(Number of animals affected by cancers of a given species) ÷ (the total number of animals for a given species examined and listed in the Marine Mammal Database of the AFIP) × 100.used in human studies, like that used in SLE
beluga, is derived from periodic census; in
contrast, the data obtained from domestic
animals originates from veterinary hospitals.
Because the latter population comprises
many (if not mostly) sick animals, the epi-
demiologic data from it are expected to con-
tain a higher rate of animals with cancer
than those of the general population of
domestic animals (34,35).
In addition, free-ranging animals gener-
ally have a shorter life span than do domestic
animals because of predation (including
hunting by humans), harsh environmental
conditions, and malnutrition. Older animals
are more numerous in the pet animal popu-
lation than in free-ranging animals because
of the absence of adverse conditions and
because of curative and preventive improve-
ments in veterinary medicine (15). Because
the risk of developing cancer increases with
age, cancer rates in pet, zoo, and aquarium
animals are expected to be higher than in
free-ranging mammals (36).
Considered together, these observations
indicate that cancer rates in domestic ani-
mals as shown in Figure 4 are overestimated.
Yet for all cancer types, the AAR in SLE bel-
uga is much higher than that observed in
cattle, horse, and sheep examined in veteri-
nary hospitals, higher than the rate observed
in dogs and cats examined in veterinary hos-
pitals, and higher than the rate in humans.
Possible etiologic factors. Cancer of the
proximal intestine is rare in all animal
species and in humans. It is frequent, how-
ever, in certain bovine and ovine populations
in certain parts of the world where it has
been etiologically associated with the inges-
tion of herbicides such as 2,4-dichlorophe-
noxyacetic acid (37–40).
In cattle, small intestinal cancers result
from an interaction between exogenous car-
cinogens and viruses. Bovine papillomavirus
type 4 causes papillomas in the bovine upper
digestive tract. In cattle infected with that
virus and fed with bracken fern (which con-
tains powerful carcinogens), papillomas
become malignant and are accompanied by
intestinal adenomas and adenocarcinomas
(37). A similar interplay between a virus and
environmental carcinogenic compounds may
be at work in SLE beluga, because gastric
papillomatosis has been observed in a signiﬁ-
cant number of carcasses, and particles con-
sistent with papillomaviruses have been
observed in papillomas (5,41).
Carcinogens are present in the environ-
ment of SLE beluga and are likely ingested
by these animals. The tissue benzo[a]pyrene
concentrations of blue mussels were 200
times higher after their transplantation into
the Saguenay River than before (42). The
sediments of the Saguenay River, which is a
part of the SLE beluga habitat, contain
500–4,500 ppb of total PAH (dry weight), a
concentration level signiﬁcantly higher than
within Osaka harbor, where PAH concentra-
tions are 2,870 ppb, and these compounds
originate from aluminum smelters located
upstream (Figure 5) (43).
Belugas dig into sediments (44), and in
the SLE they feed on signiﬁcant amounts of
bottom invertebrates (45). Invertebrates liv-
ing in sediments contaminated by PAHs
accumulate these compounds, in contrast to
vertebrates (46). Probably because of this diet
and this feeding behavior, benzo[a]pyrene
DNA adducts have been detected in stranded
SLE beluga tissue by acid hydrolysis of DNA
followed by high-performance liquid chro-
matography (HPLC) and ﬂuorescence detec-
tion, whereas they have not been detected in
Arctic beluga tissue, which live in a presum-
ably less contaminated environment (5,47).
However, no differences between the two
populations were observed in another study
where livers were analyzed by 32P postlabel-
ing (48). These apparently conﬂicting results
are not surprising given that 32P postlabeling
is highly sensitive for the detection of a vari-
ety of bulky DNA adducts but does not
allow the precise identiﬁcation of these com-
pounds. In contrast, acid hydrolysis of DNA
followed by HPLC and fluorescence detec-
tion allows the specific quantitation of
benzo[a]pyrene diolepoxide, the ultimate
carcinogenic form of benzo[a]pyrene.
Considered together, these observations sug-
gest that SLE beluga ingest PAHs present in
benthic invertebrates, which may contribute
to the elevated rate of digestive tract cancers
seen in this population (5,22,49).
A causal relationship between intestinal
adenocarcinoma and PAHs is further sup-
ported by the observation that in mice,
chronic ingestion of coal tar mixtures (which
contains benzo[a]pyrene) causes small
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Total cancer
Sheep
Horse
Cat
Dog
Cattle
Human
Beluga
Epithelial cancer, small intestine
Epithelial cancer, stomach
Epithelial cancer, GI tract
Mammary gland cancer
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41
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0
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0
2.2
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56
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0 0.5
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134
Figure 4. Adjusted annual rate (cases per 100,000) of cancer in the SLE beluga compared with that of
humans and domestic animals (34,35,92–94).
490–1,272
1,273–2,054
2,055–2,835
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(ppb, dry weight)
Figure 5. Saguenay River, Québec, Canada. Polycyclic aromatic hydrocarbon concentration in sediments
(parts per billion, dry weight) (43). Chimney icon: aluminum smelters.intestinal adenocarcinoma, forestomach
papilloma, and gastric carcinoma (50). In
humans, the ingestion of smoked food
(which contains benzo[a]pyrene) and cancer
of the small intestine have been etiologically
related (51).
Cytochrome P450 (CYP) present in the
small intestinal epithelium is among the ﬁrst
and among the major enzyme molecules
implicated in the biotransformation and
subsequent detoxication or toxification of
ingested xenobiotics, and high levels of
intestinal CYP have been related with gas-
trointestinal cancer (52). In the rat small
intestine, the highest CYP concentrations
occur in the duodenum, and the most abun-
dant CYP is CYP1A1, known to activate
PAHs into carcinogenic metabolites. It is the
most abundant inducible form, and its
inducibility decreases dramatically from the
duodenum to the ileum (53,54).
Cetaceans have high levels of CYP1A and
low levels of CYP2B. Compared with Arctic
beluga, SLE belugas have elevated levels of
both types of enzymes, probably because
CYP are induced by exposure to high levels
of PCBs [reviewed by Muir et al. (7)].
Considered together, the above observations
suggest that intestinal CYP1A levels are ele-
vated in SLE beluga and that these high lev-
els may trigger the development of intestinal
cancer by activating ingested PAHs into car-
cinogenic compounds. Besides inducing CYP
enzymes, PCBs are also known immunosup-
pressive compounds. The possibility that
PCB-induced diminished immunosurveil-
lance contributes to cancer etiology has been
discussed elsewhere (55).
A relation between ingestion of carcino-
gens and cancer in wildlife is not without
precedent. In bottom-dwelling fish, labial
papilloma and liver cancer are strongly asso-
ciated with chemical contamination of sedi-
ments (56). Lake whitefish (LWF) are the
only salmonids feeding on benthic fauna.
Tissue concentrations of organochlorine
compounds (OC) and of heavy metals found
in LWF living in the SLE are three to five
times higher than those of sympatric fish
species (including nonsalmonid bottom-
dwelling species), and these high concentra-
tions coincide with a high prevalence of liver
cancer in LWF (57,58). Thus, beluga and
LWF, two aquatic vertebrate species that
widely diverge taxonomically, may both be
affected by cancer because both feed on the
bottom, an unusual feature within their
respective taxonomic group.
Mammary gland cancers were the cause of
death of three (7.7%) of the adult female bel-
uga examined from 1983 to 1999 (23).
Mammary gland cancers have not been
reported in other marine mammals and are
rare in herbivores, including cattle, which are
phylogenetically close to cetaceans; only iso-
lated cases have been reported in other free-
ranging wildlife species (59,60). In contrast,
these tumors are common in humans, domes-
tic carnivores, and rodents. These cancers
have been etiologically related with viruses
only in rodents [although retroviral sequences
have recently been found in human cancerous
breast (61)]. In women, these cancers have
been related etiologically with OCs and PAHs
(62–64). Alternatively, or concurrently with
OCs and PAHs, these tumors may develop
because of the extended hormonal stimula-
tion associated with the long pregnancy and
lactation of cetaceans (65).
In the Saguenay–Lac Saint-Jean region,
aluminum workers are affected by a high
prevalence of lung and urinary bladder can-
cer. These cancers have been epidemiologi-
cally related with exposure to coal tar volatile
components produced by the combustion of
carbon anodes used for the electrolysis of
aluminum (66,67). Elsewhere, gastric can-
cers have been also epidemiologically related
with working in aluminum plants where car-
bon anodes are prebaked (68).
The incidence of cancer of the stomach,
digestive tract, and breast is also higher in the
Saguenay population that does not work in
the aluminum industry (10) (Figures 1 and
5). This high cancer incidence could be
related to the fact that the drinking water of
79% of the population comes from local sur-
face water (rivers and lakes) and that large
quantities of PAHs have been, and are,
released locally into the atmosphere by local
aluminum smelters (69,70). Because of cheap
hydroelectricity and accessibility to the sea,
aluminum smelters have been in operation in
that region since as early as 1926. Between
1937 and 1980, 40,000 tons of PAHs gener-
ated by the aluminum smelters have accumu-
lated in the fjord watershed, from which 20
tons are released per year and from which 3%
are benzo[a]pyrene, a strong carcinogen (71).
Both the magnitude and the persistence of
this threat to public health have been clearly
recognized (71).
Together, these observations suggest that
a human population and a population of
long-lived, highly evolved mammals may be
affected by specific types of cancer because
they share the same habitat and are exposed
to the same environmental contaminants.
In people, genetic susceptibility to cancer
takes two forms: hereditary cancer syn-
dromes (HCSs) such as familial adenoma-
tous polyposis, and population susceptibility,
where an ensemble of individuals has an
increased risk of cancer (but not as high as in
HCSs). Because inbreeding has led to some
degree of genetic homogeneity in SLE bel-
uga, the possibility of an HCS within the
SLE beluga population has to be considered
(72). HCSs affect multiple—and most often
young—members of a same family (73,74).
Beluga with cancer were not younger than
beluga dead of other causes (Table 1, Figure
2). In addition, other genetically homoge-
neous free-ranging or captive wildlife popu-
lations have not been found affected by high
rates of cancer (75,76). An apparent excep-
tion is the highly inbred black-footed ferret
(Mustela nigripes), where a high prevalence
of cancers has been observed. However, all
black-footed ferrets affected by cancer have
been kept in captivity. Captivity greatly
extends the life span of these animals, from 4
years in the wild to 7–9 years in captivity.
Because all tumors develop only in ferrets
older than 5 years, captivity clearly plays a
major role in the etiology of these tumors by
extending life span (77). In addition, these
animals may have been exposed to carcino-
genic compounds in captivity. Thus, there is
no evidence supporting that cancer in SLE
beluga is a hereditary cancer syndrome.
In population susceptibility to cancer, an
ensemble of individuals has increased risk of
developing cancer because these individuals
have a speciﬁc and common genetic feature
caused by normal polymorphism (73). This
feature most often inﬂuences the metabolism
of carcinogenic xenobiotics. It can be envis-
aged that some SLE beluga have highly
induced CYP1A1 in the proximal intestinal
epithelium, rendering cells susceptible to
mutagenesis by DNA-damaging metabolites
generated from specific xenobiotics such as
benzo[a]pyrene.
There is no evidence that cancer is fre-
quent in beluga as a species. A single case of
cancer is listed among the 56 belugas listed in
the Marine Mammal Database (Table 3). The
few signiﬁcantly prevalent cancers observed in
wild mammals have a viral etiology.
Two lines of evidence are not consistent
with the high rate of cancer being caused by
old age. First, SLE beluga affected with can-
cer did not reach the maximum life span
reached by Arctic beluga; and second, SLE
beluga with cancer showed the same age dis-
tribution as did beluga dead of other causes
(Figure 2).
Future studies. Few odontocetes species
feed on benthic invertebrates: the Amazon
river dolphin (Inia geoffrensis), the Franciscana
(Phocoena blainvillei), the Susu (P. gangetica),
and the Irrawaddy dolphin (Orcinus brevi-
rostris) (78). Because these species generally
inhabit rivers that are often more contami-
nated than the open ocean, high rates of can-
cers of the gastrointestinal tract may also be
found in these species.
Several chemical carcinogens leave a signa-
ture on the host genome by causing mutations
at speciﬁc sites in genes involved in cell pro-
liferation, such as p53 and ras. The ﬁnding
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uga, fish, and humans would strongly sup-
port the etiologic role of contaminants in
carcinogenesis (79,80).
Because cancer is an ultimate but rare
consequence of chemical mutagenesis, the
epidemiologic association of xenobiotics
with carcinogenesis requires the examination
of large numbers of animals. To demonstrate
the role of xenobiotics in carcinogenesis in
SLE beluga, convincing statistics would
require much larger numbers of whales
and/or the follow-up of SLE beluga for
many more decades. The observation of high
prevalences of cancer in other populations of
marine mammals similarly exposed to car-
cinogens would strengthen an etiologic rela-
tionship with chemical carcinogenesis.
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